1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs
Fibrinolysis is a natural process that ensures blood fluidity through the removal of fibrin deposits. However, excessive fibrinolytic activity can lead to complications in different circumstances, such as general surgery or severe trauma. The current antifibrinolytic drugs in the market, aminocaproi...
Main Authors: | Bosch-Sanz, Oriol, Rabadà, Yvette, Biarnés, Xevi, Pedreño, Javier, Caveda, Luis, Balcells, Mercedes, Martorell, Jordi, Sánchez-García, David |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Published: |
Multidisciplinary Digital Publishing Institute
2022
|
Online Access: | https://hdl.handle.net/1721.1/146827 |
Similar Items
-
Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives
by: Rabadà, Yvette, et al.
Published: (2024) -
Crystal and molecular structures of two triazole derivatives: 4-Cyclopropyl-4,5-dihydro-1H-1,2,3-triazole and Methyl 1-benzyl-1H-1,2,3-triazole-4-carboxylate
by: Boechat, N., et al.
Published: (2010) -
4-(4-Hydroxymethyl-1H-1,2,3-triazol-1-yl)Benzoic Acid
by: Ishak, D.H.A., et al.
Published: (2011) -
Synthesis & complexation of tripodal tris (1,2,3-triazol-5-ylidene) mesoionic carbene ligands
by: Laxmi, Shoba
Published: (2018) -
Uremic Serum and Solutes Increase Post-Vascular Interventional Thrombotic Risk Through Altered Stability of Smooth Muscle Cell Tissue Factor
by: Chitalia, Vipul C., et al.
Published: (2016)